Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02153619 · ClinicalTrials.gov registry record · NA
Development of Psychotherapeutic Interventions for Parents Who Lost a Child
A NA study of Parents Who Have Lost a Child, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT02153619: Active NA study of Parents Who Have Lost a Child, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02153619 is a NA study of Parents Who Have Lost a Child that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02153619, a NA study of Parents Who Have Lost a Child, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
Many parents who have lost a child use counseling or other resources to help with the emotional burden of their loss. The aim of this study is to begin to test a new counseling program for parents who have lost a child.
Conditions Studied
Interventions
- BEHAVIORAL Meaning-Centered Grief Therapy (MCGT)
- BEHAVIORAL Supportive Psychotherapy (SP)
- BEHAVIORAL questionnaires assessments
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2014-05 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT02153619 still lists
NCT02153619 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Parents Who Have Lost a Child appearing as the primary indexed condition, and to 3 interventions - of which Meaning-Centered Grief Therapy (MCGT) is the first listed.
NCT02153619 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02153619 about?
NCT02153619 is a clinical study titled "Development of Psychotherapeutic Interventions for Parents Who Lost a Child". Many parents who have lost a child use counseling or other resources to help with the emotional burden of their loss. The aim of this study is to begin to test a new counseling program for parents who have lost a child.
What is the current status of trial NCT02153619?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2014-05. Estimated completion is 2026-05.
What conditions does trial NCT02153619 study?
This clinical trial studies the following conditions: Parents Who Have Lost a Child.
What interventions are being tested in trial NCT02153619?
The interventions under investigation include: Meaning-Centered Grief Therapy (MCGT) (BEHAVIORAL), Supportive Psychotherapy (SP) (BEHAVIORAL), questionnaires assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02153619?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02153619 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02153619's enrollment target sits among peer trials
108 825th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia